From: Human breast cancer cells educate macrophages toward the M2 activation status
Factor | Entire series | CD68a | P b | CD163a | P b | HLA-Drαa | P b | |||
---|---|---|---|---|---|---|---|---|---|---|
≤369 | >369 | ≤167.5 | >167.5 | ≤107 | >107 | |||||
n = 562 | n = 277 | n = 274 | n = 270 | n = 267 | n = 280 | n = 275 | ||||
Age, years | ||||||||||
≤50 | 213 | 95 | 113 | 105 | 98 | 112 | 100 | |||
>50 | 349 | 182 | 161 | 0.093 | 165 | 169 | 0.602 | 168 | 175 | 0.378 |
Tumor size median | ||||||||||
≤22 mm | 283 | 144 | 132 | 137 | 129 | 140 | 138 | |||
>22 mm | 278 | 132 | 142 | 0.348 | 132 | 138 | 0.545 | 139 | 137 | 1.000 |
N.A. | 1 | |||||||||
Nodal status | ||||||||||
pN0 | 65 | 27 | 37 | 28 | 33 | 37 | 28 | |||
pN+ | 497 | 250 | 237 | 0.169 | 242 | 234 | 0.468 | 243 | 247 | 0.267 |
Histological type | ||||||||||
Ductal | 399 | 181 | 211 | 171 | 213 | 204 | 192 | |||
Lobular | 110 | 66 | 43 | 69 | 33 | 47 | 60 | |||
Other | 53 | 30 | 20 | 0.010 | 30 | 21 | <0.001 | 29 | 23 | 0.274 |
Histological grade | ||||||||||
Grade 1 | 46 | 33 | 13 | 26 | 16 | 20 | 25 | |||
Grade 2 | 264 | 138 | 119 | 153 | 97 | 127 | 132 | |||
Grade 3 | 250 | 106 | 140 | 0.001 | 91 | 152 | <0.001 | 131 | 118 | 0.518 |
N.A. | 2 | |||||||||
ER status | ||||||||||
Positive | 405 | 215 | 181 | 214 | 171 | 191 | 207 | |||
Negative | 157 | 62 | 93 | 0.003 | 56 | 96 | <0.001 | 89 | 68 | 0.065 |
HER-2 status | ||||||||||
Positive | 170 | 85 | 83 | 72 | 93 | 93 | 77 | |||
Negative | 392 | 192 | 191 | 0.920 | 198 | 174 | 0.040 | 187 | 198 | 0.183 |
Biological group | ||||||||||
ER+, HER-2− | 314 | 165 | 142 | 173 | 123 | 139 | 168 | |||
ER+, HER2+ | 91 | 50 | 39 | 41 | 48 | 52 | 39 | |||
ER-, HER2+ | 79 | 35 | 44 | 31 | 45 | 41 | 38 | |||
ER-, HER2− | 78 | 27 | 49 | 0.015 | 25 | 51 | <0.001 | 48 | 30 | 0.032 |
Ki67 | ||||||||||
≤20 % | 271 | 149 | 116 | 158 | 96 | 124 | 140 | |||
>20 % | 242 | 104 | 134 | 0.005 | 92 | 144 | <0.001 | 126 | 116 | 0.252 |
N.A. | 49 |